Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

Dajin Heavy Industry (大金重工) A+H IPO: Analysis of Deal Terms

Dajin Heavy Industry (大金重工) A+H Pre-IPO: Early Thought

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

Dajin Heavy Industry / Equity Capital Markets

<ul>
<li>Dajin Heavy raised HKD 6,465m (USD 826m) from its global offering and will list on the Hong Kong Stock Exchange on Friday, June 5, 2026.</li>
<li>In our previous note, we looked at the company's fundamentals and the deal terms.</li>
<li>In this note, we provide an update for the IPO before its trading debut.</li>
</ul>


Dajin Heavy raised HKD 6,465m (USD 826m) from its global offering and will list on the Hong Kong Stock Exchange on Friday, June 5, 2026.
In our previous note, we looked at the company's fundamentals and the deal terms.
In this note, we provide an update for the IPO before its trading debut.


Xinjiang Goldwind Science & Technology (002202 CH)

Dajin Heavy Industry (大金重工) A+H IPO Trading